ArticleBioengineering (Basel, Switzerland)2026
Defocus-Incorporated Multiple-Segment (DIMS) Spectacle Lenses Versus Single-Vision Lenses for Myopia Control in a South-Eastern European Population.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMyopia is a refractive error reaching alarmingly high levels worldwide and is associated with severe complications such as: maculopathy, retinal detachment, open-angle glaucoma, and posterior subcapsular cataract. The study compared two treatment strategies: defocus-incorporated multi-segment (DIMS) spectacle lenses and single-vision (SV) lenses.
methods201 children (mean age 10.92 ± 2.11 years, range, 7-17 years) were included in the study (104 patients, DIMS group; 97 patients, SV group). The ophthalmological examination included best corrected visual acuity (BCVA), cycloplegic refractive measurement (SER), eye movement evaluation, cover test, prism cover-uncover tests for near and distance, slit-lamp evaluation, fundus examination and ocular biometry.
resultsThe mean SER progression in the right eye over the 12-month follow-up was -0.29 ± 0.3 D in the DIMS group and -0.58 ± 0.45 in the SV group. Children wearing DIMS exhibited significantly less myopia progression (
conclusionsDIMS lenses are an effective treatment in myopia management in the Caucasian population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.